A UK-first Nugenyx guide to peptide product formats, research categories, single products, and research sets, with clear boundaries around evidence and use guidance.
Read more...
A clear UK-first explainer on what the approval of Wegovy tablets means, why oral GLP-1 medicines matter, and where readers should be careful about hype, shortcuts, and unsupported claims.
Read more...
A practical guide to reading peptide evidence, including cell studies, animal research, human trials, Russian and regional literature, practitioner discussion, and anecdotal reports.
Read more...
A clear UK guide to peptides, covering what they are, why they matter in biology, how peptide research is discussed, and how to read peptide claims with confidence.
Read more...
Learn what Selank is, why it appears in neuropeptide research, what human and preclinical evidence actually looks like, and how UK readers should interpret anecdotal discussion with care.
Read more...
A practical guide to Semax, its Russian research history, the cognitive and neuroplasticity themes around it, and how to interpret study regimens and anecdotal reports.
Read more...
A reader-friendly explanation of why CJC-1295 and Ipamorelin are commonly discussed together in growth hormone signalling, recovery research, and peptide protocols.
Read more...
An educational guide to CJC-1295, DAC terminology, and growth hormone signalling research, separating mechanistic rationale from unapproved health or performance claims.
Read more...
A reader-friendly guide to Ipamorelin, growth hormone secretagogue research, recovery conversations, study context, and how protocol discussions should be interpreted.
Read more...
A research-led explainer on MOTS-c, mitochondrial signalling, and metabolic resilience concepts, with careful separation between preclinical findings, human research, and open questions.
Read more...
A research and regulatory overview of GLP-1 medicines, retatrutide, and triple-agonist biology, written to clarify the difference between approved medicines, investigational drugs, and public discussion.
Read more...